In June 2016, Dan Dalton was named Senior Vice President and Chief Compliance Officer of Avanir Pharmaceuticals.
Dan came to Avanir Pharmaceuticals with over 25 years of experience working with Pharmaceutical and Medical Device companies. After practicing law at a major Philadelphia based national law firm, Dan spent 18 years at Merck & Co., Inc. Dan held several senior level legal positions supporting Merck’s U.S.-based pharmaceutical and vaccine business. Dan has also served as the Chief Compliance officer at Salix Pharmaceuticals and Hill-Rom Holdings and brings significant experience advising commercialization stage pharmaceutical companies.
Dan earned his J.D. from the University of Pennsylvania Law School and his B.S. and MBA from Lehigh University.